What does CHAMPIONS ONCOLOGY, INC. (CSBR) do?

CHAMPIONS ONCOLOGY, INC. (CSBR) is a publicly traded company in the Healthcare sector.

What sector does CSBR operate in?

CHAMPIONS ONCOLOGY, INC. operates in the Healthcare, specifically within the Biological Products, (No Diagnostic Substances) industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find CSBR earnings analysis?

AlphaOS publishes an earnings intelligence page for CHAMPIONS ONCOLOGY, INC. (CSBR) covering results, guidance context, and AI-assisted analysis. See /stocks/CSBR/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

CSBR

CHAMPIONS ONCOLOGY, INC.

Healthcare · Biological Products, (No Diagnostic Substances)

$5.29Sep 22, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

CHAMPIONS ONCOLOGY, INC. shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +9% YoY in Q1 FY2027.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +9% YoY in Q1 FY2027

Pipeline evidence · 0d ago

CSBR's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on CSBR.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2027

Full CSBR earnings analysis

Reported figures for CHAMPIONS ONCOLOGY, INC. — research only, not investment advice.

Revenue YoY: +8.8%

Latest Intelligence

Updated September 30, 2026

What happened recently for CHAMPIONS ONCOLOGY, INC. (CSBR) — events, not interpretation.

Event: Reported Q1 2027 revenue +9% YoY.
Also: Last session September 22, 2026 at $5.29.
Source: Q1 2027 earnings

Research & analysis only — not investment advice.

Building company intelligence…

CHAMPIONS ONCOLOGY, INC. (CSBR)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for CHAMPIONS ONCOLOGY, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biological Products, (No Diagnostic Substances)
Market cap:: $73.63M
Revenue:: $13.84M

CSBR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow CHAMPIONS ONCOLOGY, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.